Ruben A. Mesa, MD, Summarizes Results of the PERSIST-1 Study on Myelofibrosis

2015 ASCO Annual Meeting
Tweet this page

Ruben A. Mesa, MD, of the Mayo Clinic, discusses pacritinib and its significant efficacy in myelofibrosis (Abstract LBA7006).

Advertisement

Advertisement



Advertisement